EATG » Tuberculosis

Tuberculosis

Petition to BRICS countries to triple funding for TB R&D

>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response. On 15 November 2016 over 200 petitioners from around the world asked Ministers of…

Online resource offers platform for clinicians and researchers working on drug-resistant TB

ATLANTA, Ga –An interactive online portal now allows clinicians and researchers across five countries heavily affected by drug-resistant tuberculosis to exchange and analyze information that includes X-rays, scans, genomic information…

Call to Action to meet global HIV and TB commitments in middle-income countries

On October 27 - 28th, a group of 35 advocates from around the world attended a meeting, Financing HIV and TB Services and Advocacy in Middle Income Countries: Developing an Action…

New toolkit supports communities to demand optimal HIV treatment

Revised, updated and expanded Advocacy for Community Treatment (ACT) Toolkit launched at Regional activist workshops in Panama and South Africa The second edition of the Advocacy for Community Treatment (ACT)…

Eastern European and Central Asian countries unite to expand access to HIV and TB treatment

Health ministers from eastern Europe and central Asia adopted on 3 November in Minsk, Belarus, a consensus statement on HIV and tuberculosis (TB) treatment for all, calling for expanded and…

Dolutegravir-based ART in combination with rifampicin-based TB treatment is safe in a small cohort of co-infected patients

Twice daily dolutegravir in combination with rifampicin was well tolerated and produced good outcomes in a small retrospective study presented at HIV Drug Therapy Glasgow 2016.    A rifampicin-based regimen…

New TB compound to be developed for Pan-TB regimen

During the 47th Union World Conference on Lung Health, Otsuka Pharmaceutical, the manufacturer of delamanid, announced the development of a second anti-TB compound in its portfolio currently in Phase 1…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 299 of the “Global Fund Observer.”

Global health funding faces a shortfall of billions to fight diseases

The ecstatic press releases started even before the conference to replenish the Global Fund to Fight AIDS, Tuberculosis and Malaria officially closed last month in Montreal. The fund, which channels…

On the question of patient centred TB care in Eastern Europe and Central Asia

Two blogs authored by Evgenia Geliukh and Paul Sommerfeld comment on the advocacy needed for transition to patient centred TB care in the Eastern European and Central Asian countries. The…